OBAT operates factory with a capacity of 750,000 capsules per day
19 Feb 2025 15:43
OBAT is confident that sales may grow threefold following the new plant operating at Sukoharjo.
Targeting triple revenue, OBAT inaugurates new factory
10 Feb 2025 09:47
OBAT eyes threefold revenue increase this year following the completion of its latest factory in Sukoharjo.
IDX welcomes 3 new issuers, Aguan’s included
12 Jan 2025 07:53
These three companies are engaged in the healthcare and property segment, one of which belongs to the property mogul Aguan.
Brigit Biofarmaka seeks fresh funds through IPO
23 Dec 2024 11:53
The IPO proceeds will be allocated to purchase raw materials, increase production capacity, and develop marketing.
UNTR held Regional Coordination Meeting SOBAT 2023 with schools in Central Java
29 Aug 2023 16:10
Through its program, Sekolah Binaan UT (SOBAT) or UT development schools, PT United Tractors Tbk (UNTR) held a Regional Coordination Meeting (RCM) of Central Java and Yogyakarta Special Region in State High School 1 of Adiwerna, Tegal, Central Java, on February 4, 2023.
Brand-name drugs sales rose 14.9%, Phapros’s profit still declined
27 Jul 2023 15:58
Although its profit went down by almost 30% in the first half of 2023, PT Phapros Tbk (PEHA) managed to record an increase in brand-name drugs sales.
Q1 2023 performance slows down, PEHA to give out dividend
08 Jun 2023 17:33
PT Phapros Tbk (PEHA), a pharmaceutical product manufacturer, readies dividend of IDR 11.2 billion that will be taken out of its net profit in 2022.
Phapros prepares ethical drug to become growth pillar for 2023
02 May 2023 18:03
PT Phapros Tbk (PEHA) posted growth in sales of ethical drugs, namely branded prescription drugs, up to 8.9% year-on-year (yoy) at the end of the first quarter of 2023
Revenue down 60.56%, Indofarma's loss worsened
03 Apr 2023 06:01
The revenue of PT Indofarma Tbk (INAF), a pharmaceutical company, was seen declining 60.56% year-on-year (yoy).
Kalbe Farma scored IDR 3.45 trllion profit
30 Mar 2023 10:45
PT Kalbe Farma Tbk (KBLF), a pharmaceutical company, gains IDR 3.45 trillion in 2022, shifting 6.7% from IDR 3.23 trillion in 2021. The small jump resulted from annual increase in its revenue.